Skip to content
PubMed This is a summary of 33 peer-reviewed journal articles Updated
Medical Genetics

What Specialists Treat Fabry Disease? Care Team Guide

At a Glance

Fabry disease requires a multidisciplinary care team led by a medical geneticist or metabolic specialist. Because the disease affects multiple organs, your core specialists will also include a cardiologist for your heart, a nephrologist for your kidneys, and a neurologist for pain management.

Because Fabry disease affects many different organs in the body, your care cannot be managed by just one doctor [1]. The condition involves the buildup of a fatty substance called globotriaosylceramide (Gb3), which slowly accumulates in different tissues over time [1]. To effectively monitor and treat the disease, you will need a multidisciplinary care team (MDT) made up of several specific specialists [2]. The core experts usually include a medical geneticist to lead the team, a cardiologist for your heart, a nephrologist for your kidneys, a neurologist for your nervous system, and an ophthalmologist for your eyes [3][4].

As a newly diagnosed patient, looking at a long list of specialists can feel overwhelming. Please know that you do not need to book appointments with all of them by next week. Building this team is a gradual process [2]. Your geneticist or team leader is step one, and they will help you prioritize which baseline evaluations you need first over the coming months.

The Core Specialists

Medical Geneticist or Metabolic Specialist (The Team Leader)

A medical geneticist or metabolic specialist is usually the “quarterback” of your Fabry care team [5]. Because Fabry is an inherited genetic condition linked to the X chromosome, these doctors specialize in how the disease is passed down and how it affects the body’s metabolism [1][6]. They will:

  • Confirm your diagnosis by checking enzyme levels in your blood (especially for males) and performing genetic sequencing of the GLA gene [7].
  • Oversee main treatments like enzyme replacement therapy (ERT) or chaperone therapy, which aim to clear Gb3 from your cells [8][9].
  • Guide your overall care plan and help direct referrals to other specialists [5][10]. Note: While they lead the team, doctors in different clinics don’t always communicate perfectly. You or a care coordinator will often need to advocate for yourself and ensure your records are shared between offices.
  • Provide genetic counseling and assist with cascade testing (family screening) to help you understand if other family members should be tested [6].

Cardiologist (Heart Specialist)

Gb3 buildup in the heart muscle can cause the walls of your heart to thicken, a condition known as left ventricular hypertrophy (LVH), and can lead to scar tissue (fibrosis) [11][12]. A cardiologist will monitor your heart health using advanced imaging tools like echocardiograms or cardiovascular magnetic resonance (CMR), as well as an electrocardiogram (ECG) to check for irregular heartbeats [11][13]. They watch for signs of heart strain and help manage these risks early [14].

Nephrologist (Kidney Specialist)

Your kidneys act as the body’s filters, but Gb3 buildup can slowly damage the tiny structures inside them, leading to glomerular and tubular dysfunction [15]. A nephrologist tracks your kidney function, often by checking for protein in your urine (proteinuria) or analyzing your blood [16][17]. Catching kidney stress early is critical to preventing long-term chronic kidney disease [18].

Neurologist (Nerve and Brain Specialist)

Many people with Fabry disease experience severe, burning pain in their hands and feet (acroparesthesia) caused by Gb3 buildup in the peripheral sensory nerves [19][20]. A neurologist specializes in the nervous system and can help manage this chronic neuropathic pain [21][22]. They also monitor for central nervous system issues, as Fabry disease can increase the risk of stroke or changes in brain tissue [4][22].

Ophthalmologist (Eye Specialist)

Fabry disease causes distinct changes in the eyes, most notably cornea verticillata, which are harmless, whorl-like patterns on the surface of the eye [23][24]. An ophthalmologist can often spot these patterns during a slit-lamp exam [25]. While these eye changes rarely affect your vision, they are strong markers of the disease and help your doctors track the condition [26][23].

Additional Specialists You May Need

Depending on your specific symptoms, your team leader might also refer you to:

  • Dermatologist: To evaluate and manage skin manifestations like angiokeratomas (small, dark red spots) [27][28].
  • Gastroenterologist: To manage digestive issues like abdominal pain, bloating, or diarrhea, which are very common in Fabry disease [29].
  • Audiologist or ENT: To evaluate and treat hearing loss, ringing in the ears (tinnitus), or balance issues [30][31].
  • Medical Social Worker or Care Coordinator: Because treatments for Fabry disease are highly specialized and often expensive, these professionals are invaluable for navigating insurance, specialty pharmacies, and scheduling complex care [32][33].
  • Psychologist or Counselor: To provide emotional support, as managing a lifelong, chronic condition can take a toll on mental health [30].

A Tip for Managing Your Team: Managing appointments for multiple specialists can feel like a part-time job. Consider creating a physical “Fabry Binder” or a dedicated digital folder. Keeping your own copies of lab results, imaging reports, and doctor notes ensures that no matter which specialist you are seeing that day, they have the complete picture of your health. Having a multidisciplinary team in place helps ensure that treatments begin early, which has been shown to delay disease progression and improve long-term outcomes [10].

Common questions in this guide

Which specialist usually leads a Fabry disease care team?
A medical geneticist or metabolic specialist typically leads your care team. They specialize in inherited conditions, confirm your diagnosis, and oversee primary treatments like enzyme replacement therapy.
Why do I need to see a cardiologist for Fabry disease?
Fabry disease can cause a fatty substance to build up in the heart muscle, leading to thickening and scar tissue. A cardiologist will monitor your heart health using imaging tools and electrocardiograms to catch and manage any heart strain early.
What kidney specialist treats Fabry disease?
A nephrologist monitors and treats your kidneys. They track your kidney function by checking for protein in your urine to catch any damage early and prevent long-term chronic kidney disease.
Which specialists should I prioritize seeing first?
You should work with your geneticist or metabolic specialist to prioritize your baseline evaluations based on your specific symptoms. You do not need to see every specialist immediately, as building your care team is a gradual process.
How do I organize my medical records for multiple specialists?
Keeping a physical binder or a dedicated digital folder for your medical records is highly recommended. Bringing your own copies of lab results and imaging reports to each appointment ensures all your specialists have the complete picture of your health.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who will act as the primary 'quarterback' for my care, and do you have a dedicated nurse coordinator for Fabry patients?
  2. 2.Which of these specialist appointments should I prioritize booking first for my baseline evaluations?
  3. 3.Are my enzyme levels and genetic mutation type known to cause classic or late-onset symptoms, and how does that change which specialists I need to see?
  4. 4.What is the best way to ensure my test results and imaging are shared seamlessly between all members of my care team?
  5. 5.Are there any clinical trials or newer therapies for Fabry disease that I should discuss with the metabolic specialist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (33)
  1. 1

    Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.

    Lenders M, Brand E

    Journal of the American Society of Nephrology : JASN 2018; (29(9)):2265-2278 doi:10.1681/ASN.2018030329.

    PMID: 30093456
  2. 2

    European expert consensus statement on therapeutic goals in Fabry disease.

    Wanner C, Arad M, Baron R, et al.

    Molecular genetics and metabolism 2018; (124(3)):189-203 doi:10.1016/j.ymgme.2018.06.004.

    PMID: 30017653
  3. 3

    [The nephropathy in the Anderson-Fabry disease: new recommendations for the diagnosis, the follow-up and the therapy].

    Mignani R, Gallieni M, Feriozzi S, et al.

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 2015; (32(4)).

    PMID: 26252265
  4. 4

    Stroke and Chronic Kidney Disease in Fabry Disease.

    Tapia D, Kimonis V

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2021; (30(9)):105423 doi:10.1016/j.jstrokecerebrovasdis.2020.105423.

    PMID: 33160817
  5. 5

    Multidisciplinary Care Model as a Center of Excellence for Fabry Disease: A Practical Guide to Diagnosis and Management by Clinical Specialty in South Korea.

    Lee SY, Kim IY, Ahn SH, et al.

    Journal of clinical medicine 2025; (14(13)) doi:10.3390/jcm14134400.

    PMID: 40648776
  6. 6

    Low frequency of Fabry disease in patients with common heart disease.

    Schiffmann R, Swift C, McNeill N, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(7)):754-759 doi:10.1038/gim.2017.175.

    PMID: 29227985
  7. 7

    The unlikely combination: Anderson-Fabry disease and congenital dyserythropoietic anemia type II in a pediatric patient.

    Elsherif Y, Ibrahim IA, Elsherif O, Abukhadijah HJ

    Clinical case reports 2024; (12(10)):e9354 doi:10.1002/ccr3.9354.

    PMID: 39386347
  8. 8

    Effects of Enzyme Replacement Therapy on Cardiac MRI Findings in Fabry Disease: A Systematic Review and Meta-Analysis.

    Figliozzi S, Kollia E, Simistiras A, et al.

    Radiology. Cardiothoracic imaging 2024; (6(3)):e230154 doi:10.1148/ryct.230154.

    PMID: 38842453
  9. 9

    The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.

    Germain DP, Arad M, Burlina A, et al.

    Molecular genetics and metabolism 2019; (126(3)):224-235 doi:10.1016/j.ymgme.2018.09.007.

    PMID: 30413388
  10. 10

    Screening for Fabry Disease in Kidney Transplant Recipients: Experience of a Multidisciplinary Team.

    Veroux M, Monte IP, Rodolico MS, et al.

    Biomedicines 2020; (8(10)) doi:10.3390/biomedicines8100396.

    PMID: 33036343
  11. 11

    Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy.

    Nordin S, Kozor R, Bulluck H, et al.

    Journal of the American College of Cardiology 2016; (68(15)):1707-1708 doi:10.1016/j.jacc.2016.07.741.

    PMID: 27712787
  12. 12

    Echocardiography in Anderson-Fabry Disease.

    Lillo R, Pieroni M, Camporeale A, et al.

    Reviews in cardiovascular medicine 2022; (23(6)):201 doi:10.31083/j.rcm2306201.

    PMID: 39077168
  13. 13

    Arrhythmia and Clinical Cardiac Findings in Children With Anderson-Fabry Disease.

    Wilson HC, Hopkin RJ, Madueme PC, et al.

    The American journal of cardiology 2017; (120(2)):251-255 doi:10.1016/j.amjcard.2017.04.016.

    PMID: 28550929
  14. 14

    Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease.

    Halfmann MC, Altmann S, Schoepf UJ, et al.

    European radiology 2023; (33(3)):2039-2051 doi:10.1007/s00330-022-09183-7.

    PMID: 36322192
  15. 15

    Renal involvement in Fabry disease.

    Abensur H, Reis MA

    Jornal brasileiro de nefrologia 2016; (38(2)):245-54.

    PMID: 27438980
  16. 16

    Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy.

    Fall B, Scott CR, Mauer M, et al.

    PloS one 2016; (11(12)):e0168346 doi:10.1371/journal.pone.0168346.

    PMID: 27992580
  17. 17

    Urine-derived renal epithelial cells for deep phenotyping and transcriptomic response to therapy in Fabry disease.

    Sudhindar PD, Orr SE, Miller-Hodges E, et al.

    Clinical science (London, England : 1979) 2025; (139(14)) doi:10.1042/CS20255570.

    PMID: 40673439
  18. 18

    Insights of Fabry disease: Expert consensus approach for screening, diagnosis, and multidisciplinary management in chronic kidney disease.

    Lin CJ, Yang FJ, Wu CJ, et al.

    Journal of the Formosan Medical Association = Taiwan yi zhi 2025; (124(9)):794-799 doi:10.1016/j.jfma.2024.09.033.

    PMID: 39358116
  19. 19

    Sensory-specific peripheral nerve pathology in a rat model of Fabry disease.

    Waltz TB, Burand AJ, Sadler KE, Stucky CL

    Neurobiology of pain (Cambridge, Mass.) 2021; (10()):100074 doi:10.1016/j.ynpai.2021.100074.

    PMID: 34541380
  20. 20

    Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment.

    Politei JM, Bouhassira D, Germain DP, et al.

    CNS neuroscience & therapeutics 2016; (22(7)):568-76 doi:10.1111/cns.12542.

    PMID: 27297686
  21. 21

    Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.

    Tuttolomondo A, Baglio I, Riolo R, et al.

    International journal of molecular sciences 2023; (25(1)) doi:10.3390/ijms25010061.

    PMID: 38203231
  22. 22

    Cryptogenic strokes and neurological symptoms of Fabry disease.

    Ruiz-Franco ML, Vélez-Gómez B, Martínez-Sánchez P, et al.

    Frontiers in neurology 2025; (16()):1529267 doi:10.3389/fneur.2025.1529267.

    PMID: 40109843
  23. 23

    Ocular findings and their correlation with disease severity in Fabry disease in South-East Anatolia.

    Mete A, Dogan L, Ozcakmakci GB, et al.

    International ophthalmology 2023; (43(7)):2301-2306 doi:10.1007/s10792-022-02626-6.

    PMID: 36595126
  24. 24

    Prevalence of Fabry disease in cryptogenic stroke: a systematic review and meta-analysis with meta-regression.

    Magalhães PLM, Gonçalves OR, Meira OT, et al.

    Journal of neurology 2025; (272(11)):720 doi:10.1007/s00415-025-13464-8.

    PMID: 41123702
  25. 25

    Ocular and confocal manifestations of Mainland Chinese with Fabry disease: a cross-sectional controlled study.

    Xu Y, Chen Y, Fan J, et al.

    Orphanet journal of rare diseases 2025; (20(1)):417 doi:10.1186/s13023-025-03940-9.

    PMID: 40784937
  26. 26

    Evaluation of corneal morphology, pupillometry, and ocular surface parameters in Fabry disease patients: correlation with plasma Lyso-Gb3 levels.

    Dal A, Kutluksaman B, Akikol T, et al.

    International ophthalmology 2026; (46(1)).

    PMID: 42274905
  27. 27

    Angiokeratomas, not everything is Fabry disease.

    Cuestas D, Perafan A, Forero Y, et al.

    International journal of dermatology 2019; (58(6)):713-721 doi:10.1111/ijd.14330.

    PMID: 30656678
  28. 28

    The Renal History of Fabry Disease.

    Gaggl M, El-Hadi S, Aigner C, Sunder-Plassmann G

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 2016; (33 Suppl 66()):33.S66.14.

    PMID: 26913882
  29. 29

    Gastrointestinal involvement in Fabry disease. So important, yet often neglected.

    Politei J, Thurberg BL, Wallace E, et al.

    Clinical genetics 2016; (89(1)):5-9 doi:10.1111/cge.12673.

    PMID: 26333625
  30. 30

    Association of Fabry Disease with Hearing Loss, Tinnitus, and Sudden Hearing Loss: A Nationwide Population-Based Study.

    Cheng YF, Xirasagar S, Chen CS, et al.

    Journal of clinical medicine 2022; (11(24)) doi:10.3390/jcm11247396.

    PMID: 36556012
  31. 31

    A Case of Fabry Disease With Lacrimal Gland Involvement.

    Bruce CN, Mancera N, Grover A, Esmaili N

    Ophthalmic plastic and reconstructive surgery 2023; (39(2)):e52-e55 doi:10.1097/IOP.0000000000002312.

    PMID: 36728127
  32. 32

    The Prolonged Hospital Stays at Nigerian Teaching Hospitals: Roles of Medical Social Workers.

    Oyinlola O, Adeleke RO, Afolabi A

    Ethiopian journal of health sciences 2024; (34(5)):421-424 doi:10.4314/ejhs.v34i5.11.

    PMID: 39944386
  33. 33

    Overcoming Barriers to Eye Care: Patient Response to a Medical Social Worker in a Glaucoma Service.

    Fudemberg SJ, Amarasekera DC, Silverstein MH, et al.

    Journal of community health 2016; (41(4)):845-9 doi:10.1007/s10900-016-0162-1.

    PMID: 26860278

This page provides educational information about building a Fabry disease multidisciplinary care team. It is for informational purposes only and does not replace professional medical advice.

Get notified when new evidence is published on Fabry disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.